The psychedelic renaissance is well and truly underway throughout much of the world. It’s headlined by no small number of careful and well-meaning scientists from some of the world’s most reputable institutions. But psychedelic use itself, of course, interwoven throughout the development of human culture for thousands of years, never really went away. It simply went underground, out of majority consciousness.
As awareness of the unique properties of psychedelic compounds and the experiences they are famed for continues to grow, it is important that mature discussion take place regarding their nature, utility, and relevance for modern humanity. Such a discussion is one for the world to continue to grapple with over many years. Generally speaking, things left in the shadow too long tend to get restless.
This podcast was recorded at an event titled Psychedelics & The Future. I was joined by Executive Officer of Mind Medicine Australia, Melissa Warner. Mind Medicine Australia acts as the central node for the promotion of regulatory approved and research backed psychedelic medicines to assist with the treatment of mental health. Much of this conversation turned on the science of psychedelic medicines, their effect on the brain, and guidelines for therapeutic use.
About Melissa Warner
Melissa is co-founder and Executive Officer of Mind Medicine Australia, and board member of PRISM (Psychedelic Research in Science and Medicine). She is a commentator on the science and philosophy of psychedelic substances on radio, print and online. Melissa holds a BSc in Neuroscience with a minor in computer programming. She is an avid meditator, yogi, performance artist, bio-hacker, and futurist. Her intellectual focus is currently the development of tools and frameworks to facilitate creative output, personal healing, and self-actualization. A survivor of complex PTSD, she lives as a case study for the efficacy of psychedelics as therapeutic tools.